Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Danielle McCartney, Thomas R. Arkell, Christopher Irwin, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 126, pp. 175-193
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 133
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Marco Solmi, Marco De Toffol, Jong Yeob Kim, et al.
BMJ (2023), pp. e072348-e072348
Open Access | Times Cited: 114
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
Shalini Shah, Eric S. Schwenk, Rakesh V. Sondekoppam, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 3, pp. 97-117
Open Access | Times Cited: 57
Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta‐review of meta‐analyses
Laura Dellazizzo, Stéphane Potvin, Sabrina Giguère, et al.
Addiction (2022) Vol. 117, Iss. 7, pp. 1857-1870
Closed Access | Times Cited: 68
Driving Performance and Cannabis Users’ Perception of Safety
Thomas D. Marcotte, Anya Umlauf, David J. Grelotti, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 3, pp. 201-201
Open Access | Times Cited: 54
An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives
Xiuli Wang, Huanbang Zhang, Yan Liu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106810-106810
Closed Access | Times Cited: 26
Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits
Eva Hoch, Nora D. Volkow, Chris M. Friemel, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 9
The why behind the high: determinants of neurocognition during acute cannabis exposure
Johannes G. Ramaekers, Natasha L. Mason, Lilian Kloft, et al.
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 7, pp. 439-454
Closed Access | Times Cited: 54
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
Caroline A. MacCallum, Lindsay A. Lo, Michael Boivin
European Journal of Internal Medicine (2021) Vol. 89, pp. 10-18
Open Access | Times Cited: 52
Cannabis and Driving
Godfrey D. Pearlson, Michael C. Stevens, Deepak Cyril D’Souza
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 52
Cannabinoids, Insomnia, and Other Sleep Disorders
Isobel Lavender, Iain S. McGregor, Anastasia Suraev, et al.
CHEST Journal (2022) Vol. 162, Iss. 2, pp. 452-465
Closed Access | Times Cited: 29
Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
Lindsay A. Lo, April Christiansen, Justin C. Strickland, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 9, pp. 1425-1436
Open Access | Times Cited: 7
Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
Caroline A. MacCallum, Lauren Eadie, Alasdair M. Barr, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Simulated driving performance among daily and occasional cannabis users
Ashley Brooks‐Russell, Timothy L. Brown, Kyle Friedman, et al.
Accident Analysis & Prevention (2021) Vol. 160, pp. 106326-106326
Open Access | Times Cited: 35
Medical cannabis and driving
Thomas R. Arkell, Danielle McCartney, Iain S. McGregor
Australian Journal of General Practice (2021) Vol. 50, Iss. 6, pp. 357-362
Open Access | Times Cited: 33
The Place of Cannabinoids in the Treatment of Gynecological Pain
Justin Sinclair, Jason Abbott, Andrew Proudfoot, et al.
Drugs (2023) Vol. 83, Iss. 17, pp. 1571-1579
Open Access | Times Cited: 15
Trends in emergency department visits associated with cannabis use among older adults in California, 2005–2019
Benjamin H. Han, Jesse J. Brennan, Mirella A. Orozco, et al.
Journal of the American Geriatrics Society (2023) Vol. 71, Iss. 4, pp. 1267-1274
Closed Access | Times Cited: 14
A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance
Brooke Manning, Thomas R. Arkell, Amie C. Hayley, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 247-257
Open Access | Times Cited: 5
A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood
Brooke Manning, Amie C. Hayley, Sarah Catchlove, et al.
European Neuropsychopharmacology (2024) Vol. 82, pp. 35-43
Open Access | Times Cited: 5
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial
Peter Grimison, Antony Mersiades, Adrienne Kirby, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 34, pp. 4040-4050
Closed Access | Times Cited: 5
The driving‐related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation
Danielle McCartney, Cilla Zhou, Isobel Lavender, et al.
Drug and Alcohol Review (2025)
Open Access
The role of cannabinoid-mediated signaling pathways and mechanisms in brain disorders
Shunfeng Liu, Zegang Ma
Cellular Signalling (2025), pp. 111653-111653
Closed Access
Identifying EEG markers related to acute cannabis consumption: A systematic review
C Schiemer, Mathew J. Summers, Kayla B. Stefanidis
Neuroscience & Biobehavioral Reviews (2025), pp. 106092-106092
Open Access
Dose-response relationship between blood concentrations of THC and crash culpability risk: An updated meta-regression of culpability studies
Matthew A. Albrecht, Razi Hasan, Damir Kekez, et al.
Drug Science Policy and Law (2025) Vol. 11
Closed Access
Standard THC units: A tool to benchmark cannabis-related driving risks
Valentina Lorenzetti, Tom P. Freeman, Amie C. Hayley
International Journal of Drug Policy (2025) Vol. 139, pp. 104788-104788
Open Access
Page 1 - Next Page

Scroll to top